Tuesday, May 14, 2019

Orchid Pharma gets ANDA nod from USFDA for Risedronate Sodium tablets

Orchid Pharma has received ANDA approval from USFDA for Risedronate Sodium Tablets USP, 30 mg and 35 mg.

from India Infoline News Service http://bit.ly/2VW6zZF
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)